Global Endoluminal Suturing Devices Market Assessment, By Product [Endovascular Suturing Devices, Endoscopic Suturing Devices, Consumables], By Component [Cannula, Needle, Suction Port], By Application [Gastrointestinal Surgery, Bariatric Surgery, Gastroesophageal Reflux Disease, Thoracic Procedures, Urological Procedures, Others], By End-User [Hospitals, Ambulatory Surgical Centers, Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F

Global endoluminal suturing devices market is projected to witness a CAGR of 10.05% during the forecast period 2024-2031, growing from USD 91.28 million in 2023 to USD 196.38 million in 2031F. The expansion of the market is supported by the increase in preference for non-invasive surgical procedures, growth in prevalence of gastrointestinal cancer, and the expansion of the healthcare sector.

The increasing prevalence of chronic diseases is one of the major global endoluminal suturing devices market trends. This increase is propelling the requirement for various efficient surgical solutions, including endoluminal suturing devices, as they play a crucial role in gastrointestinal surgeries, bariatric surgeries, gastroesophageal reflux disease, thoracic procedures, and urological procedures, among others. In bariatric surgery, these devices are deployed for performing different procedures, including gastric bypass and gastric sleeve, aiding patients in managing obesity-related comorbidities by achieving weight loss. The increased preference for these devices can also be attributed to their ability to treat the health condition in a minimally invasive manner, provide faster recovery and reduce surgical risks and improving the quality of life of the patient.

The rising emphasis on increasing the efficiency and cost-effectiveness of healthcare systems is providing lucrative growth opportunities for the market. Endoluminal suturing devices aid healthcare providers in reducing costs associated with extended hospital stays while allowing them to optimize resources. The growing number of cases of gastrointestinal disorders is further boosting the requirement for endoluminal suturing devices. According to a questionnaire survey conducted from July 2022 to May 2023, in Hainan, the prevalence of functional gastrointestinal diseases was 32%. The growing investments towards the enhancement of healthcare infrastructure and rapid population expansion are other major factors boosting the global endoluminal suturing devices market size.

Download Free Sample Report

Increasing Preference for Minimally Invasive Procedures Supports Market Expansion

The rising preference for minimally invasive procedures due to growing awareness about the various advantages associated with them is positively influencing the expansion of the market. Minimally invasive procedures are linked with fewer complications, less pain, and shorter hospitalizations. These devices aid surgeons in performing precise suturing in anatomically challenging locations and body cavities. The greater maneuverability and control offered by the devices further allow surgeons to achieve optimal surgical outcomes. The devices are also associated with faster recovery times, reduced risk of infection, and improved patient satisfaction. Endoluminal suturing devices also eliminate the requirement for large incisions by allowing surgeons to suture tissues internally, thus boosting their demand and positively influencing market expansion.

Technological Advancements Boost Global Endoluminal Suturing Devices Market

The increasing research and development efforts to support the enhancement of the functionality, ease of use, and precision offered by endoluminal suturing devices are driving the growth of the market. The utilization of robotic technology provides surgeons with dexterous and precise motions along with ergonomic and intuitive manipulation. The increased preference for minimal invasiveness during surgeries, coupled with technological advancements in robotics, has supported the emergence of flexible surgical robots. Additionally, the incorporation of imaging technologies, such as endoscopy and fluoroscopy, provides real-time visualization that improves procedural outcomes during the suturing process. Technological advancements will support the development of advanced endoluminal suturing devices that will feature data management capabilities and wireless connectivity, allowing the real-time monitoring of surgical metrics and device parameters, thus providing lucrative growth opportunities to the market.

The rising investments by various key market players in research and development will also support the development of technologically advanced endoluminal suturing devices. In 2022, Boston Scientific launched a state-of-the-art research and development center in Pune. The center provides expertise in diverse areas, including endoscopy, urology, cardiology, and neuromodulation, among others.

North America Holds Significant Share of the Market

The presence of a well-established healthcare infrastructure, the increasing requirement for surgical procedures, and the strong placement of various leading market players are some of the factors supporting the growth of the North America endoluminal suturing devices market. The growth of the market in the region can also be attributed to the introduction of favorable reimbursement policies and the availability of a large patient pool. The demand for minimally invasive procedures is also increasing in countries such as Canada and the United States, as they reduce the risk of infection, blood loss, scarring, and time of recovery. Endoluminal suturing devices allow surgeons to internally perform suturing with smaller incisions, playing an essential role in such procedures. The rise in the number of bariatric procedures in the region is further boosting the expansion of the market in North America. According to the estimates of the American Society for Metabolic and Bariatric Surgery, the total number of bariatric surgeries conducted in 2022 was 279,967.

Gastrointestinal Surgery Dominates the Market

The rising requirement for gastrointestinal surgeries can be attributed to the increasing occurrence of gastrointestinal perforations, severe acid reflux, inflammatory bowel disease, and gastrointestinal cancer. According to the estimates of the International Agency for Research on Cancer, gastrointestinal cancer accounts for one in three cancer related deaths and one in four cancer cases across the globe.

Gastrointestinal perforations occur because of surgical complications, ulcers, and trauma. The endoluminal suturing devices are used for closing these perforations in order to prevent the leakage of gastric contents in the abdominal cavity. Therefore, the availability of effective endoluminal suturing devices is essential for the proper management of gastrointestinal perforations. Endoluminal suturing devices also allow surgeons to endoscopically close leaks that can occur at the site of anastomosis after gastrointestinal surgeries, avoiding the requirement for additional invasive surgeries.

Hospitals Account for a Significant Global Endoluminal Suturing Devices Market Share

The segment expansion is supported by the increased requirement for surgical procedures in various regions across the globe. The rising demand for surgical procedures can be attributed to the growing prevalence of chronic health diseases that require surgical procedures for further exploration of the condition in order to give an appropriate diagnosis. These procedures also help in treating various pathological conditions, such as malignancy, trauma, and injury. The rising investments by various hospitals to meet evolving patient requirements and provide advanced medical care is another major factor bolstering the demand for endoluminal suturing devices from hospitals. In April 2024, the construction of UCSF Health Helen Diller Hospital was initiated. The hospital is expected to cost USD 4.3 billion and will have 15 stories. The design of this new hospital will integrate care and advanced science to provide a healing habitat for the patients. The facility will have the latest technologies in diagnostics, robotics, and surgical procedures. The construction of such state-of-the-art facilities in this evolving landscape of healthcare is a testament to the commitment provided by the sector to support the advancement of patient care.

Future Market Scenario (2024-2031F)

According to the global endoluminal suturing devices market analysis, the market is anticipated to witness significant growth over the forecast period 2024-2031. This growth can be attributed to expanding healthcare sector, rising investments in research and development activities, and increasing prevalence of various health conditions such as gastrointestinal perforations, severe acid reflux, inflammatory bowel disease, and gastrointestinal cancer. The increasing collaborations between healthcare providers and medical device manufacturers will drive innovation, supporting the development of advanced endoluminal devices and boosting the expansion of the market.

Report Scope

“Endoluminal Suturing Devices Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the global endoluminal suturing devices market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031F. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.

Report Attribute	Details
Base Year of the Analysis	2023
Historical Period	2017-2022
Forecast Period	2024-2031F
Projected Growth Rate	CAGR of 10.05% between 2024-2031F
Revenue Forecast in 2031	USD 196.38 million
Segments Covered	Product, Component, Application, End-user
Regions Covered	North America, Europe, South America, Asia-Pacific, Middle East and Africa
Key Companies Profiled	Apollo Endosurgery, Inc. (Boston Scientific Corporation), B. Braun SE, Medtronic plc, Johnson & Johnson, Cook Medical, Endo Tools Therapeutics S.A., USGI, Medical, Inc., Stryker Corporation, Ovesco Endoscopy AG, ErgoSuture
Customization Scope	15% free report customization with purchase
Pricing and Purchase Options	Avail the customized purchase options to fulfill your precise research needs
Delivery Format	PDF and Excel through email (subject to the license purchased)

In this report, the global endoluminal suturing devices market has been segmented into the following categories:

• By Product
  • Endovascular Suturing Devices
  • Endoscopic Suturing Devices
  • Consumables
• By Component
  • Cannula
  • Needle
  • Suction Port
• By Application
  • Gastrointestinal Surgery
  • Bariatric Surgery
  • Gastroesophageal Reflux Disease
  • Thoracic Procedures
  • Urological Procedures
  • Others
• By End-User
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others
• By Region
  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

Key Players Landscape and Outlook

The key players of the endoluminal suturing devices market include Apollo Endosurgery, Inc. (Boston Scientific Corporation), B. Braun SE, Medtronic plc, Johnson & Johnson, and Cook Medical. The expansion of the market is supported by increasing investments in research and development activities, collaborations, and successful mergers and acquisitions.

In 2023, Boston Scientific successfully completed the acquisition of Apollo Endosurgery. Apollo’s product portfolio includes different devices required in endoluminal surgery procedures. The endoluminal surgery procedures aid in managing gastrointestinal complications and close gastrointestinal defects. These procedures are also employed due to their less-invasive nature as opposed to laparoscopic and open surgeries. With the closure of this acquisition, the companies aim to provide a comprehensive suite of endobariatric and endoluminal surgery solutions to their patients.

Key Players Operating in the Global Endoluminal Suturing Devices Market are:

• Apollo Endosurgery, Inc. (Boston Scientific Corporation)
• Braun SE
• Medtronic plc
• Johnson & Johnson
• Cook Medical
• Endo Tools Therapeutics S.A.
• USGI, Medical, Inc.
• Stryker Corporation
• Ovesco Endoscopy AG
• ErgoSuture

Markets and Data report answers the following questions:

• What is the current and future market size of the product in question globally or specific to different countries?
• How are the markets divided into different product segments and the market size and growth of each segment?
• What is the market potential of different product segments and their investment case?
• How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
• What is the business environment and regulatory landscape specific to the product/service?

If you can't find what you're searching for or have any custom requirements for the global endoluminal suturing devices market, you may approach our team at info@marketsandata.com.